TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
May 09 2023 - 6:00AM
TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical
technology company focused on providing innovative soft-tissue
reconstruction solutions that optimize clinical outcomes by
prioritizing the preservation and restoration of the patient's own
anatomy, will sponsor a Women in Surgery Dinner on May 10, 2023, at
the International Hernia Collaboration (IHC) Conference in Rio de
Janeiro, Brazil.
Surgery has traditionally been a male-dominated
specialty despite the increasing number of women graduating
from medical schools. Events like the Women in Surgery dinner are
critical in bringing together female surgeons, residents, medical
students, and other healthcare professionals to network, share
their experiences, and discuss ways to promote gender equity in
surgery.
"The Women in Surgery Dinner is a unique event
that brings together women in all stages of their surgical career
to network with colleagues and share their professional
experiences," said Talar Tejirian MD, IHC Program Co-Chair. "This
event was created out of necessity. When I was in my residency,
there were no female attendings. I didn’t have women in my field
that I could turn to for support and mentorship. As I advanced in
my career, I wanted to create a space to connect with women in
surgery. I’m proud to have been invited back by the IHC to organize
another Women in Surgery Dinner to empower women in hernia surgery
and beyond.”
The Women in Surgery Dinner is dedicated to
celebrating and supporting women in the field of surgery.
Co-founded in 2019 by Dr. Tejirian, she continues to volunteer her
time to organize the event on behalf of the IHC.
“At TELA Bio, we understand that progress and
innovation are only possible when we embrace and empower diverse
perspectives,” said Gina M. Nagvajara, PhD, Vice President of
Regulatory and Quality at TELA Bio. “We are honored to support the
advancement of women in surgery, and I am happy to be representing
our company culture of continued learning and inclusivity during
the IHC Brazil meeting."
Marissa Conrad, Vice President of Clinical
Affairs and Project Management, and d. Richard St. Arromand,
Director of Hernia Sales & Account Manager Development, will be
joining Dr. Nagvajara in representing TELA Bio at the IHC Brazil
from May 9-12, 2023, at the Hilton Rio de Janeiro, Brazil.
IHC Brazil is an international event for
surgeons, healthcare providers, and industry professionals
interested in the repair of hernias and optimizing outcomes to come
together to collaborate, share, and discuss challenges and
solutions related to the disease of hernia.
https://www.herniagroup.com/ihc-2023-brazil/
About TELA Bio, Inc.TELA Bio,
Inc. (NASDAQ: TELA) is a commercial-stage medical technology
company focused on providing innovative technologies that optimize
clinical outcomes by prioritizing the preservation and restoration
of the patient's own anatomy. The Company is committed to providing
surgeons with advanced, economically effective soft-tissue
reconstruction solutions that leverage the patient's natural
healing response while minimizing long-term exposure to permanent
synthetic materials. For more information, visit
www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010ir@telabio.com
Media ContactAlyson
Kuritz908-892-7149alyson@0to5.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2024 to May 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From May 2023 to May 2024